Request Discount

Preclinical Imaging Market (Product - Modalities, and Reagents; Application - Research and Development, and Drug Discovery; End-user - Pharmaceutical Companies, Biotech Companies, and Research Institutes): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

  • Published : August, 2019

  • Rep Id : HC0658

  • Category : Healthcare & Medical Devices

  • Status : Published

This report provides exclusive insights into the COVID-19 impact on the Preclinical Imaging Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Preclinical Imaging Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Preclinical Imaging Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.

A recent report published by Infinium Global Research on preclinical imaging market provides an in-depth analysis of segments and sub-segments in the global as well as regional preclinical imaging market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional preclinical imaging market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global preclinical imaging market. According to the report, the global preclinical imaging market is projected to grow at a CAGR of 5.3% over the forecast period of 2019-2025.


Market Insight

Preclinical imaging is used in live animal for drug development. Further, it is used to monitor the treatment response of efficacy. This imaging continues to provide crucial data sets to scientists in cardiology, neurology and metabolic disease. A small animal imaging provides a piece of spatially, quantitative and temporally-indexed information on diseased and normal tissues such as tumors. This allows monitoring of diseases progression as well as treatment options over a period of time. The most used imaging modalities are positron emission tomography (PET), optical (bioluminescence and fluorescence), magnetic resonance imaging (MRI). The multiple imaging modalities are provided information on molecular features, metabolism, and function all within the context of anatomical structure and localization.


The growth in the prevalence of chronic diseases such as cancer, cardiovascular, rheumatoid arthritis, and neurological disorders are driving the global preclinical imaging market. Further, government funding for research and development activities, technological advancements in the field of molecular imaging and growing demand for non-invasive imaging techniques provides a demand for the market. However, high operation and installation cost associated with preclinical imaging are hindering the growth of the market. Moreover, growing research infrastructure provides growth opportunities for preclinical imaging market.


North America is anticipated to dominate the preclinical imaging market owing to growth in the prevalence of chronic diseases such as cancer, rapid adoption of several types of modalities by the end-user, cardiovascular disease, and technological advancement. Europe is the second-largest region for the preclinical imaging market owing to the increasing number of research and development activities and growing health care awareness among people. The Asia-Pacific is expected to grow with healthy CAGR owing to government support for research and development activities, growing population and opportunity for clinical and preclinical studies at low cost.


Segment Covered

The report on global preclinical imaging market covers segments such as product, application, and end-user. On the basis of product, the sub-markets include modalities, and reagents. On the basis of application, the sub-markets include research and development, and drug discovery. On the basis of end-user, the sub-markets include pharmaceutical companies, biotech companies, and research institutes.


Companies Profiled:

The report provides profiles of the companies in the market such as MR Solutions, TriFoil Imaging, Bruker Corporation, PerkinElmer Inc, FUJIFILM Holdings America Corporation, Mediso Ltd, Miltenyi Biotec, Aspect Imaging, Li-Cor Biosciences, and MILabs B.V.


Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of preclinical imaging market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.

Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount